Yingjie Nie
Shenzhen, 518053, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Combination of APS, HMGN1, and anti-TNFR2 antibody remodels the tumor immune microenvironment to enhance antitumor immunity in colorectal cancer.
Journal: Translational oncology
Published: March 09, 2026
Environmental enrichment suppresses colorectal cancer progression with comorbid depression by modulating the immunosuppressive tumor microenvironment.
Journal: Biochemical and biophysical research communications
Published: February 24, 2026
Investigating the efficacy of propranolol in treating chronic stress combined with colorectal cancer in mice and its antitumor potential.
Journal: European journal of pharmacology
Published: February 16, 2026
3M-052 combined inhibitory anti-TNFR2 synergistically suppresses colon cancer progression.
Journal: Frontiers in immunology
Published: November 18, 2025
In situ DC-primed vaccine combined with CD137 agonist elicits long-lasting antitumor immunity through cDC1-mediated tumor antigen-specific CD8+ T cell responses.
Journal: Journal for immunotherapy of cancer
Published: November 15, 2025
Anti-TNFR2 antibody and HMGN1 combined with TIL cell therapy inhibits colorectal cancer progression by enhancing immune response.
Journal: Biochemical and biophysical research communications
Published: April 01, 2025
Ansofaxine suppressed NSCLC progression by increasing sensitization to combination immunotherapy.
Journal: International immunopharmacology
Published: September 21, 2024
Intratumoral injection of R848 and poly(I:C) synergistically promoted antitumor immune responses by reprogramming macrophage polarization and activating DCs in lung cancer.
Journal: Clinical and experimental immunology
Published: May 13, 2024
The combination of a PTP1B inhibitor, TNFR2 blocker, and PD‑1 antibody suppresses the progression of non‑small cell lung cancer tumors by enhancing immunocompetence.
Journal: Oncology reports
Published: April 05, 2024
Enhancing the revelation of key genes and interaction networks in non-small cell lung cancer with major depressive disorder: A bioinformatics analysis.
Journal: Health science reports
Published: December 30, 2023
Combinational delivery of TLR4 and TLR7/8 agonist enhanced the therapeutic efficacy of immune checkpoint inhibitors to colon tumor.
Journal: Molecular and cellular biochemistry
Published: December 24, 2023
Last Updated: 09/26/2026